USANA Health Sciences, Inc.

Historical 13F Holders

Symbol
USNA
CUSIP
90328M107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 90328M107 since 12/18/2024, largest first.

Filer % of Class Filed
Myron W. Wentz 13D/A
40.1% 3/30/2026
Event 3/26/2026
Pzena Investment Management LLC 13G/A 6.6% 10/14/2025
Event 9/30/2025
Renaissance Technologies LLC 13G/A
5.2% 8/13/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Dimensional Fund Advisors LP 13G/A 4.6% 1/21/2026
Event 12/31/2025
BlackRock, Inc. 13G/A 4.4% 1/21/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 6 5.35 k $77.3 k
2026 Q2 142 12.2 M $261 M
2026 Q1 140 10.3 M $180 M
2025 Q4 123 10.5 M $206 M
2025 Q3 168 12.8 M $372 M
2025 Q2 168 11.1 M $339 M
2025 Q1 165 10.8 M $290 M
2024 Q4 155 10.8 M $387 M
2024 Q3 152 10.7 M $405 M
2024 Q2 161 10.5 M $475 M
2024 Q1 169 10.7 M $521 M
2023 Q4 174 10.8 M $580 M
2023 Q3 166 10.3 M $603 M
2023 Q2 173 10.3 M $647 M
2023 Q1 186 10.5 M $660 M
2022 Q4 173 10.9 M $580 M
2022 Q3 175 10.2 M $574 M
2022 Q2 185 10.5 M $760 M
2022 Q1 182 10.5 M $833 M
2021 Q4 196 10.7 M $1.08 B
2021 Q3 186 10.8 M $994 M
2021 Q2 196 11.1 M $1.14 B
2021 Q1 207 11.5 M $1.12 B
2020 Q4 202 12.0 M $930 M
2020 Q3 201 11.9 M $876 M
2020 Q2 202 12.0 M $884 M
2020 Q1 184 11.4 M $658 M
2019 Q4 184 11.6 M $914 M
2019 Q3 178 11.7 M $799 M
2019 Q2 190 14.6 M $1.16 B
2019 Q1 201 14.3 M $1.20 B
2018 Q4 202 12.9 M $1.52 B
2018 Q3 212 14.7 M $1.77 B
2018 Q2 199 13.3 M $1.53 B
2018 Q1 174 12.3 M $1.05 B
2017 Q4 156 11.6 M $860 M
2017 Q3 150 10.9 M $621 M
2017 Q2 154 11.2 M $716 M
2017 Q1 158 11.0 M $635 M
2016 Q4 150 10.1 M $621 M
2016 Q3 139 5.05 M $699 M
2016 Q2 142 5.08 M $566 M
2016 Q1 136 5.26 M $638 M
2015 Q4 165 5.80 M $742 M
2015 Q3 166 5.87 M $790 M
2015 Q2 151 5.51 M $753 M
2015 Q1 145 5.80 M $644 M
2014 Q4 132 5.99 M $615 M
2014 Q3 125 6.22 M $458 M
2014 Q2 125 6.71 M $524 M
2014 Q1 145 7.57 M $571 M